Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03337724 |
|---|---|
| Brief Title: | A Study of Ipatasertib in Combination With Paclitaxel as a Treatment for Participants With PIK3CA/AKT1/PTEN-Altered, Locally Advanced or Metastatic, Triple-Negative Breast Cancer or Hormone Receptor-Positive, HER2-Negative Breast Cancer (IPATunity130) |
| First Submitted : | November 7, 2017 |
| First Submitted that Met QC Criteria : | November 7, 2017 |
| First Posted : | November 9, 2017 |
| Results First Submitted : | January 2, 2024 |
| Results First Posted with QC Comments : | January 24, 2024 |
| Results First Submitted that Met QC Criteria : | February 15, 2024 |
| Results First Posted : | March 12, 2024 |
| Last Update Submitted that Met QC Criteria : | February 15, 2024 |
| Last Update Posted : | March 12, 2024 |